Q J Med 2004; 97: 163-166
QJM vol. 97 no. 3 (c) Association of Physicians 2004; all rights reserved.
Commentary |
Fibrinogen, C-reactive protein and coronary heart disease: does Mendelian randomization suggest the associations are non-causal?
From the Department of Social Medicine, University of Bristol, Bristol, UK
| The first 150 words of the full text of this article appear below. |
 |
Introduction |
|---|
Two recent reviews in QJM have evaluated the role of fibrinogen1 and C-reactive protein (CRP)2 as risk factors for cardiovascular disease. Both raised fibrinogen and CRP levels clearly predict future risk of cardiovascular events, and could be used to identify those patients who would get the greatest absolute benefit from intervention targeting blood pressure and cholesterol lowering, smoking cessation or exercise promotion. The reviews also raise the issue of a causal relationship between fibrinogen or CRP and cardiovascular disease, and discuss the roles of pharmacological or lifestyle changes as means of modifying fibrinogen or CRP levels.1,2 However, doubt is cast on the causal nature of either factor by evidence produced by studies using the ‘Mendelian randomization’ paradigm.3 Here we briefly outline Mendelian randomization, and review what studies using this approach have to say regarding the potential causal roles of fibrinogen and CRP with respect to cardiovascular disease.
|
What is Mendelian randomization? |
|---|
Epidemiology aims to
|
Mendelian randomization, fibrinogen and CRP |
|---|
|
Conclusions |
|---|
Address correspondence to Professor G. Davey-Smith, Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol BS8 2PR. e-mail: zetkin@bristol.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Kivimaki, D. A. Lawlor, G. D. Smith, C. Eklund, M. Hurme, T. Lehtimaki, J. S. A. Viikari, and O. T. Raitakari Variants in the CRP Gene as a Measure of Lifelong Differences in Average C-Reactive Protein Levels: The Cardiovascular Risk in Young Finns Study, 1980 2001 Am. J. Epidemiol., October 1, 2007; 166(7): 760 - 764. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Heikkila, S. Ebrahim, and D. A Lawlor A systematic review of the association between circulating concentrations of C reactive protein and cancer J Epidemiol Community Health, September 1, 2007; 61(9): 824 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Lange, C. S. Carlson, L. A. Hindorff, E. M. Lange, J. Walston, J. P. Durda, M. Cushman, J. C. Bis, D. Zeng, D. Lin, et al. Association of Polymorphisms in the CRP Gene With Circulating C-Reactive Protein Levels and Cardiovascular Events JAMA, December 13, 2006; 296(22): 2703 - 2711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M May, D A Lawlor, P Brindle, R Patel, and S Ebrahim Cardiovascular disease risk assessment in older women: can we improve on Framingham? British Women's Heart and Health prospective cohort study Heart, October 1, 2006; 92(10): 1396 - 1401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P Casas, T. Shah, J. Cooper, E. Hawe, A. D McMahon, D. Gaffney, C. J Packard, D. S O'Reilly, I. Juhan-Vague, J. S Yudkin, et al. Insight into the nature of the CRP-coronary event association using Mendelian randomization Int. J. Epidemiol., August 1, 2006; 35(4): 922 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Smith Randomised by (your) god: robust inference from an observational study design J Epidemiol Community Health, May 1, 2006; 60(5): 382 - 388. [Full Text] [PDF]
|
|
|
|
 |
|
 S. J Lewis, S. Ebrahim, and G. Davey Smith Meta-analysis of MTHFR 677C->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate? BMJ, November 5, 2005; 331(7524): 1053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Smith, R. Harbord, J. Milton, S. Ebrahim, and J. A.C. Sterne Does Elevated Plasma Fibrinogen Increase the Risk of Coronary Heart Disease?: Evidence from a Meta-Analysis of Genetic Association Studies Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2228 - 2233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kivimaki, D. A. Lawlor, M. Juonala, G. Davey Smith, M. Elovainio, L. Keltikangas-Jarvinen, J. Vahtera, J. S.A. Viikari, and O. T. Raitakari Lifecourse Socioeconomic Position, C-Reactive Protein, and Carotid Intima-Media Thickness in Young Adults: The Cardiovascular Risk in Young Finns Study Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2197 - 2202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Smith, D. A. Lawlor, R. Harbord, N. Timpson, A. Rumley, G. D.O. Lowe, I. N.M. Day, and S. Ebrahim Association of C-Reactive Protein With Blood Pressure and Hypertension: Life Course Confounding and Mendelian Randomization Tests of Causality Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 1051 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Krieger and G. Davey Smith "Bodies Count," and Body Counts: Social Epidemiology and Embodying Inequality Epidemiol. Rev., July 1, 2004; 26(1): 92 - 103. [Full Text] [PDF]
|
|